Profile of Bacteria with ARGs Among Real-World Samples from ICU Admission Patients with Pulmonary Infection Revealed by Metagenomic NGS

References

• Mehta AB, Syeda SN, Wiener RS, et al. Epidemiological trends in invasive mechanical ventilation in the United States: a population-based study. J Crit Care. 2015;30(6):1217–1221. doi:10.1016/j.jcrc.2015.07.00726271686
   PubMed Web of Science ®Google Scholar
• Luyt CE, Hékimian G, Koulenti D, et al. Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia. Curr Opin Crit Care. 2018;24(5):332–338. doi:10.1097/MCC.000000000000052630036192
   PubMed Web of Science ®Google Scholar
• Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of America. Clin Infect Dis. 2009;48(1):1–12. doi:10.1086/59501119035777
   PubMed Web of Science ®Google Scholar
• Moore LS, Freeman R, Gilchrist MJ, et al. Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in London. J Antimicrob Chemother. 2014;69(12):3409–3422. doi:10.1093/jac/dku30725118270
   PubMed Web of Science ®Google Scholar
• Kalil AC, Metersky ML, Klompas M, et al. Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63(5):575–582. doi:10.1093/cid/ciw50427521441
   PubMed Web of Science ®Google Scholar
• Dananché C, Vanhems P, Machut A, et al. Trends of incidence and risk factors of ventilator-associated pneumonia in elderly patients admitted to French ICUs between 2007 and 2014. Crit Care Med. 2018;46(6):869–877. doi:10.1097/CCM.000000000000301929432348
   PubMed Web of Science ®Google Scholar
• Luna CM, Aruj P, Niederman MS, et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J. 2006;27(1):158–164. doi:10.1183/09031936.06.0004910516387949
   PubMed Web of Science ®Google Scholar
• MacVane SH. Antimicrobial resistance in the intensive care unit: a focus on gram-negative bacterial infections. J Intensive Care Med. 2017;32(1):25–37. doi:10.1177/088506661561989526772199
   PubMed Web of Science ®Google Scholar
• Martins ST, Moreira M, Furtado GH, et al. Application of control measures for infections caused by multi-resistant gram-negative bacteria in intensive care unit patients. Mem Inst Oswaldo Cruz. 2004;99(3):331–334. doi:10.1590/S0074-0276200400030001715273810
   PubMed Web of Science ®Google Scholar
• Sader HS, Farrell DJ, Flamm RK, et al. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY Antimicrobial Surveillance Program, 2009–2012. Int J Antimicrob Agents. 2014;43(4):328–334. doi:10.1016/j.ijantimicag.2014.01.00724630306
   PubMed Web of Science ®Google Scholar
• Torres A, Zhong N, Pachl J, et al. Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, Phase 3 non-inferiority trial. Lancet Infect Dis. 2018;18(3):285–295. doi:10.1016/S1473-3099(17)30747-829254862
   PubMed Web of Science ®Google Scholar
• Bowstead TT, Santiago SM. Pleuropulmonary infection due to Corynebacterium striatum. Br J Dis Chest. 1980;74(2):198–200. doi:10.1016/0007-0971(80)90035-27426360
   PubMedGoogle Scholar
• Alibi S, Ferjani A, Boukadida J, et al. Occurrence of Corynebacterium striatum as an emerging antibiotic-resistant nosocomial pathogen in a Tunisian hospital. Sci Rep. 2017;7(1):9704. doi:10.1038/s41598-017-10081-y28848236
   PubMed Web of Science ®Google Scholar
• Wang X, Zhou H, Chen D, et al. Whole-genome sequencing reveals a prolonged and persistent intrahospital transmission of Corynebacterium striatum, an emerging multidrug-resistant pathogen. J Clin Microbiol. 2019;57(9):e00683–19. doi:10.1128/JCM.00683-1931315959
   PubMed Web of Science ®Google Scholar
• Shariff M, Aditi A, Beri K. Corynebacterium striatum: an emerging respiratory pathogen. J Infect Dev Ctries. 2018;12(7):581–586. doi:10.3855/jidc.1040631954008
   PubMed Web of Science ®Google Scholar
• McMullen AR, Anderson N, Wallace MA, et al. When good bugs go bad: epidemiology and antimicrobial resistance profiles of Corynebacterium striatum, an emerging multidrug-resistant, opportunistic pathogen. Antimicrob Agents Chemother. 2017;61(11):e01111–17. doi:10.1128/AAC.01111-1728848008
   PubMed Web of Science ®Google Scholar
• Verroken A, Bauraing C, Deplano A, et al. Epidemiological investigation of a nosocomial outbreak of multidrug-resistant Corynebacterium striatum at one Belgian university hospital. Clin Microbiol Infect. 2014;20(1):44–50. doi:10.1111/1469-0691.1219723586637
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Y, Du X, et al. Rapid transmission of multidrug-resistant Corynebacterium striatum among susceptible patients in a tertiary hospital in China. J Infect Dev Ctries. 2016;10(12):1299–1305. doi:10.3855/jidc.757728036309
   PubMed Web of Science ®Google Scholar
• Ortiz-Pérez A, Martín-de-hijas NZ, Esteban J, et al. High frequency of macrolide resistance mechanisms in clinical isolates of Corynebacterium species. Microb Drug Resist. 2010;16(4):273–277. doi:10.1089/mdr.2010.003220624090
   PubMed Web of Science ®Google Scholar
• Otsuka Y, Ohkusu K, Kawamura Y, et al. Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseases. Diagn Microbiol Infect Dis. 2006;54(2):109–114. doi:10.1016/j.diagmicrobio.2005.08.00516406181
   PubMed Web of Science ®Google Scholar
• Ramos JN, Souza C, Faria YV, et al. Bloodstream and catheter-related infections due to different clones of multidrug-resistant and biofilm producer Corynebacterium striatum. BMC Infect Dis. 2019;19(1):672. doi:10.1186/s12879-019-4294-731357945
   PubMed Web of Science ®Google Scholar
• Asgin N, Otlu B. Antimicrobial resistance and molecular epidemiology of Corynebacterium striatum isolated in a tertiary hospital in Turkey. Pathogens. 2020;9(2):136. doi:10.3390/pathogens9020136
   PubMed Web of Science ®Google Scholar
• Schröder J, Maus I, Meyer K, et al. Complete genome sequence, lifestyle, and multi-drug resistance of the human pathogen Corynebacterium resistens DSM 45100 isolated from blood samples of a leukemia patient. BMC Genomics. 2012;13:141. doi:10.1186/1471-2164-13-14122524407
   PubMed Web of Science ®Google Scholar
• Eguchi H, Kuwahara T, Miyamoto T, et al. High-level fluoroquinolone resistance in ophthalmic clinical isolates belonging to the species Corynebacterium macginleyi. J Clin Microbiol. 2008;46(2):527–532. doi:10.1128/JCM.01741-0718077650
   PubMed Web of Science ®Google Scholar
• Campanile F, Carretto E, Barbarini D, et al. Clonal multidrug-resistant Corynebacterium striatum strains, Italy. Emerg Infect Dis. 2009;15(1):75–78. doi:10.3201/eid1501.08080419116057
   PubMed Web of Science ®Google Scholar
• Inchai J, Pothirat C, Liwsrisakun C, et al. Ventilator-associated pneumonia: epidemiology and prognostic indicators of 30-day mortality. Jpn J Infect Dis. 2015;68(3):181–186. doi:10.7883/yoken.JJID.2014.28225672347
   PubMed Web of Science ®Google Scholar
• Koulenti D, Tsigou E, Rello J. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study. Eur J Clin Microbiol Infect Dis. 2017;36(11):1999–2006. doi:10.1007/s10096-016-2703-z27287765
   PubMed Web of Science ®Google Scholar
• Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329. doi:10.1001/jama.2009.175419952319
   PubMed Web of Science ®Google Scholar
• Jia W, Li C, Zhang H, et al. Prevalence of genes of OXA-23 carbapenemase and AdeABC efflux pump associated with multidrug resistance of Acinetobacter baumannii isolates in the ICU of a comprehensive hospital of Northwestern China. Int J Environ Res Public Health. 2015;12(8):10079–10092. doi:10.3390/ijerph12081007926308027
   PubMed Web of Science ®Google Scholar
• Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence. 2012;3(5):421–433. doi:10.4161/viru.2128223076243
   PubMed Web of Science ®Google Scholar
• Cattoir V, Giard JC. Antibiotic resistance in Enterococcus faecium clinical isolates. Expert Rev Anti Infect Ther. 2014;12(2):239–248. doi:10.1586/14787210.2014.87088624392717
   PubMed Web of Science ®Google Scholar
• Fernández L, Hancock RE. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev. 2012;25(4):661–681. doi:10.1128/CMR.00043-1223034325
   PubMed Web of Science ®Google Scholar
• Palmeiro JK, de Souza RF, Schörner MA, et al. Molecular epidemiology of multidrug-resistant Klebsiella pneumonia isolates in a Brazilian tertiary hospital. Front Microbiol. 2019;10:1669. doi:10.3389/fmicb.2019.0166931396186
   PubMed Web of Science ®Google Scholar
• Pan YP, Xu YH, Wang ZX, et al. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa. Arch Microbiol. 2016;198(6):565–571. doi:10.1007/s00203-016-1215-727060003
   PubMed Web of Science ®Google Scholar
• Horna G, López M, Guerra H, et al. Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa. Sci Rep. 2018;8(1):16463. doi:10.1038/s41598-018-34694-z30405166
   PubMed Web of Science ®Google Scholar
• Mazzariol A, Zuliani J, Cornaglia G, et al. AcrAB efflux system: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob Agents Chemother. 2002;46(12):3984–3986. doi:10.1128/AAC.46.12.3984-3986.200212435706
   PubMed Web of Science ®Google Scholar
• Bernardini A, Cuesta T, Tomás A, et al. The intrinsic resistome of Klebsiella pneumoniae. Int J Antimicrob Agents. 2019;53(1):29–33. doi:10.1016/j.ijantimicag.2018.09.01230236960
   PubMed Web of Science ®Google Scholar
• Rizek CF, Jonas D, Garcia Paez JI, et al. Multidrug-resistant Stenotrophomonas maltophilia: description of new MLST profiles and resistance and virulence genes using whole-genome sequencing. J Glob Antimicrob Resist. 2018;15:212–214. doi:10.1016/j.jgar.2018.07.00930036694
   PubMed Web of Science ®Google Scholar
• Chang LL, Chen HF, Chang CY, et al. Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother. 2004;53(3):518–521. doi:10.1093/jac/dkh09414749340
   PubMed Web of Science ®Google Scholar
• Fritz CQ, Edwards KM, Self WH, et al. Prevalence, risk factors, and outcomes of bacteremic pneumonia in children. Pediatrics. 2019;144(1):e20183090. doi:10.1542/peds.2018-309031217309
   PubMed Web of Science ®Google Scholar
• Beumer MC, Koch RM, van Beuningen D, et al. Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality. J Crit Care. 2019;50:59–65. doi:10.1016/j.jcrc.2018.11.01330481669
   PubMed Web of Science ®Google Scholar
• Wierzbowski AK, Boyd D, Mulvey M, et al. Expression of the mef (E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides. Antimicrob Agents Chemother. 2005;49(11):4635–4640. doi:10.1128/AAC.49.11.4635-4640.200516251306
   PubMed Web of Science ®Google Scholar
• Izumikawa K, Yamamoto Y, Yanagihara K, et al. Active surveillance of methicillin-resistant Staphylococcus aureus with the BD GeneOhm MRSA™ assay in a respiratory ward in Nagasaki, Japan. Jpn J Infect Dis. 2012;65(1):33–36.22274155
   PubMed Web of Science ®Google Scholar
• Veloso JO, Lamaro-Cardoso J, Neves LS, et al. Methicillin-resistant and vancomycin-intermediate Staphylococcus aureus colonizing patients and intensive care unit environment: virulence profile and genetic variability. APMIS. 2019;127(11):717–726. doi:10.1111/apm.1298931407405
   PubMed Web of Science ®Google Scholar
• Ziakas PD, Anagnostou T, Mylonakis E. The prevalence and significance of methicillin-resistant Staphylococcus aureus colonization at admission in the general ICU setting: a meta-analysis of published studies. Crit Care Med. 2014;42(2):433–444. doi:10.1097/CCM.0b013e3182a66bb824145849
   PubMed Web of Science ®Google Scholar
• Qiao F, Huang W, Cai L, et al. Methicillin-resistant Staphylococcus aureus nasal colonization and infection in an intensive care unit of a university hospital in China. J Int Med Res. 2018;46(9):3698–3708. doi:10.1177/030006051877781229911488
   PubMed Web of Science ®Google Scholar
• Wang Q, Wu B, Yang D, et al. Optimal specimen type for accurate diagnosis of infectious peripheral pulmonary lesions by mNGS. BMC Pulm Med. 2020;20(1):268. doi:10.1186/s12890-020-01298-133059646
   PubMed Web of Science ®Google Scholar
• Wang Q, Miao Q, Pan J, et al. The clinical value of metagenomic next-generation sequencing in the microbiological diagnosis of skin and soft tissue infections. Int J Infect Dis. 2020;100:414–420. doi:10.1016/j.ijid.2020.09.00732898669
   PubMed Web of Science ®Google Scholar
• Hu YY, Cao JM, Yang Q, et al. Risk factors for carbapenem-resistant pseudomonas aeruginosa, Zhejiang Province, China. Emerg Infect Dis. 2019;25(10):1861–1867. doi:10.3201/eid2510.18169931538558
   PubMed Web of Science ®Google Scholar
• Huang L, Zhang R, Hu Y, et al. Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017. Antimicrob Resist Infect Control. 2019;8:90. doi:10.1186/s13756-019-0539-x31164979
   PubMed Web of Science ®Google Scholar
• Simner PJ, Miller S, Carroll KC. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis. 2018;66(5):778–788. doi:10.1093/cid/cix88129040428
   PubMed Web of Science ®Google Scholar
• Li H, Gao H, Meng H, et al. Detection of pulmonary infectious pathogens from lung biopsy tissues by metagenomic next-generation sequencing. Front Cell Infect Microbiol. 2018;8:205. doi:10.3389/fcimb.2018.0020529988504
   PubMed Web of Science ®Google Scholar
• Yuan J, Li W, Qiu E, et al. Metagenomic NGS optimizes the use of antibiotics in appendicitis patients: bacterial culture is not suitable as the only guidance. Am J Transl Res. 2021;13(4):3010–3021.34017469
   PubMed Web of Science ®Google Scholar
• Yee R, Breitwieser FP, Hao S, et al. Metagenomic next-generation sequencing of rectal swabs for the surveillance of antimicrobial-resistant organisms on the Illumina Miseq and Oxford MinION platforms. Eur J Clin Microbiol Infect Dis. 2021;40(1):95–102. doi:10.1007/s10096-020-03996-432783106
   PubMed Web of Science ®Google Scholar
• Sukhum KV, Diorio-Toth L, Dantas G. Genomic and metagenomic approaches for predictive surveillance of emerging pathogens and antibiotic resistance. Clin Pharmacol Ther. 2019;106(3):512–524. doi:10.1002/cpt.153531172511
   PubMed Web of Science ®Google Scholar
• Langelier C, Kalantar KL, Moazed F, et al. Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults. Proc Natl Acad Sci U S A. 2018;115(52):E12353–E12362. doi:10.1073/pnas.180970011530482864
   PubMed Web of Science ®Google Scholar
• Zinter MS, Dvorak CC, Mayday MY, et al. Pulmonary metagenomic sequencing suggests missed infections in immunocompromised children. Clin Infect Dis. 2019;68(11):1847–1855. doi:10.1093/cid/ciy80230239621
   PubMed Web of Science ®Google Scholar
• Schlaberg R, Chiu CY, Miller S, et al. Validation of metagenomic next-generation sequencing tests for universal pathogen detection. Arch Pathol Lab Med. 2017;141(6):776–786. doi:10.5858/arpa.2016-0539-RA28169558
   PubMed Web of Science ®Google Scholar
• Liapikou A, Cillóniz C, Torres A. Emerging strategies for the noninvasive diagnosis of nosocomial pneumonia. Expert Rev Anti Infect Ther. 2019;17(7):523–533. doi:10.1080/14787210.2019.163501031237462
   PubMed Web of Science ®Google Scholar
• Nicolau DP, Dimopoulos G, Welte T, et al. Can we improve clinical outcomes in patients with pneumonia treated with antibiotics in the intensive care unit? Expert Rev Respir Med. 2016;10(8):907–918. doi:10.1080/17476348.2016.119027727181707
   PubMed Web of Science ®Google Scholar
• Jeukens J, Freschi L, Kukavica-Ibrulj I, et al. Genomics of antibiotic-resistance prediction in Pseudomonas aeruginosa. Ann N Y Acad Sci. 2019;1435(1):5–17. doi:10.1111/nyas.1335828574575
   PubMed Web of Science ®Google Scholar
• Angers-Loustau A, Petrillo M, Bengtsson-Palme J, et al. The challenges of designing a benchmark strategy for bioinformatics pipelines in the identification of antimicrobial resistance determinants using next generation sequencing technologies. F1000Res. 2018;7:459. doi:10.12688/f1000research.14509.2
   Google Scholar
• Chen X, Ding S, Lei C, et al. Blood and bronchoalveolar lavage fluid metagenomic next-generation sequencing in pneumonia. Can J Infect Dis Med Microbiol. 2020;2020:6839103. doi:10.1155/2020/683910332879643
   PubMed Web of Science ®Google Scholar
• Murugesan K, Hogan CA, Palmer Z, et al. Investigation of preanalytical variables impacting pathogen cell-free DNA in blood and urine. J Clin Microbiol. 2019;57(11):e00782–19. doi:10.1128/JCM.00782-1931511335
   PubMed Web of Science ®Google Scholar
• Han D, Li R, Shi J, et al. Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing. Theranostics. 2020;10(12):5501–5513. doi:10.7150/thno.4555432373224
   PubMed Web of Science ®Google Scholar
• Ho J, Marks GB, Fox GJ. The impact of sputum quality on tuberculosis diagnosis: a systematic review. Int J Tuberc Lung Dis. 2015;19(5):537–544. doi:10.5588/ijtld.14.079825868021
   PubMed Web of Science ®Google Scholar
• Carnevale GG, Vargas FS, Caiaffa-Filho HH, et al. Preanalytical conditions can interfere with M. tuberculosis detection by PCR in respiratory samples. Clinics. 2018;73:e410. doi:10.6061/clinics/2017/e41030517280
   PubMed Web of Science ®Google Scholar
• Hector A, Jonas F, Kappler M, et al. Novel method to process cystic fibrosis sputum for determination of oxidative state. Respiration. 2010;80(5):393–400. doi:10.1159/00027160720029169
   PubMed Web of Science ®Google Scholar
• Sandiumenge A, Lisboa T, Gomez F, et al. Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE organisms. Chest. 2011;140(3):643–651. doi:10.1378/chest.11-046221659436
   PubMed Web of Science ®Google Scholar
• Patterson JE, Sweeney AH, Simms M, et al. An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine. 1995;74(4):191–200. doi:10.1097/00005792-199507000-000037623654
   PubMed Web of Science ®Google Scholar
• Li F, Wang Y, Sun L, Wang X. Vancomycin-resistant Enterococcus faecium pneumonia in a uremic patient on hemodialysis: a case report and review of the literature. BMC Infect Dis. 2020;20(1):167. doi:10.1186/s12879-020-4892-432087689
   PubMed Web of Science ®Google Scholar